This timeframe was chosen because we had previously demonstrated that KCC2 expression in the hippocampus recovered to sham levels in the same animal model, while the subjects exhibited cognitive dysfunction, particularly depression-like behavior (Goubert et al., 2019). This evidence concerns the gene SLC12A5 and depressive symptom measurement.